These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30522524)

  • 1. Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children.
    Akano K; Ntadom G; Agomo C; Happi CT; Folarin OA; Gbotosho GO; Mokuolu O; Finomo F; Ebenebe JC; Jiya N; Ambe J; Wammanda R; Emechebe G; Basorun OK; Wewe OA; Amoo S; Ezeigwe N; Oguche S; Fatunmbi B; Sowunmi A
    Infect Dis Poverty; 2018 Dec; 7(1):122. PubMed ID: 30522524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials.
    Ebenebe JC; Ntadom G; Ambe J; Wammanda R; Jiya N; Finomo F; Emechebe G; Mokuolu O; Akano K; Agomo C; Folarin OA; Oguche S; Useh F; Oyibo W; Aderoyeje T; Abdulkadir M; Ezeigwe NM; Happi C; Sowunmi A;
    Am J Trop Med Hyg; 2018 Sep; 99(3):649-664. PubMed ID: 29943725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials.
    Sowunmi A; Fatunmbi B; Akano K; Wewe OA; Agomo C; Finomo F; Ebenebe J; Jiya N; Ambe J; Wammanda R; Ntadom G; Mokuolu O; Emechebe G; Ezeigwe N; Ayede AI; Adewoye EO; Gbotosho GO; Folarin OA; Happi CT; Oguche S; Oyibo WA; Useh F
    BMC Infect Dis; 2017 Dec; 17(1):781. PubMed ID: 29258448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria.
    Sowunmi A; Akano K; Ayede AI; Adewoye EO; Ntadom G; Fatunmbi B; Gbotosho GO; Folarin OA; Happi CT
    BMC Infect Dis; 2017 Jan; 17(1):110. PubMed ID: 28143417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Adewoye EO; Fatunmbi B; Aderoyeje T
    Infect Dis Poverty; 2016 Jul; 5(1):70. PubMed ID: 27384596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria.
    Sowunmi A; Ntadom G; Akano K; Ibironke FO; Ayede AI; Agomo C; Folarin OA; Gbotosho GO; Happi C; Oguche S; Okafor HU; Meremikwu M; Agomo P; Ogala W; Watila I; Mokuolu O; Finomo F; Ebenebe JC; Jiya N; Ambe J; Wammanda R; Emechebe G; Oyibo W; Useh F; Aderoyeje T; Dokunmu TM; Alebiosu OT; Amoo S; Basorun OK; Wewe OA; Okafor C; Akpoborie O; Fatunmbi B; Adewoye EO; Ezeigwe NM; Oduola A
    Infect Dis Poverty; 2019 Aug; 8(1):69. PubMed ID: 31383040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Aderoyeje T; Adewoye EO; Fatunmbi B
    BMC Infect Dis; 2016 Jun; 16():240. PubMed ID: 27246468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical illness and outcomes in Nigerian children with persistent early-appearing anaemia following initiation of artemisinin-based combination treatments of uncomplicated falciparum malaria.
    Akano K; Fatunmbi B; Ntadom G; Ayede AI; Aderoyeje T; Bakre A; Alebiosu OT; Akpoborie O; Okafor C; Gbotosho GO; Folarin OA; Ebenebe JC; Ambe J; Wammanda R; Jiya N; Finomo F; Emechebe G; Mokuolu O; Agomo C; Oguche S; Happi C; Sowunmi A
    Parasite; 2019; 26():56. PubMed ID: 31516119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.
    Sowunmi A; Akano K; Ayede AI; Ntadom G; Fatunmbi B; Aderoyeje T; Adewoye EO
    BMC Infect Dis; 2015 Oct; 15():454. PubMed ID: 26502714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
    Muhindo MK; Kakuru A; Jagannathan P; Talisuna A; Osilo E; Orukan F; Arinaitwe E; Tappero JW; Kaharuza F; Kamya MR; Dorsey G
    Malar J; 2014 Jan; 13():32. PubMed ID: 24468007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.
    Michael OS; Gbotosho GO; Folarin OA; Okuboyejo T; Sowunmi A; Oduola AM; Happi CT
    Malar J; 2010 Nov; 9():335. PubMed ID: 21092220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
    Zwang J; Dorsey G; Mårtensson A; d'Alessandro U; Ndiaye JL; Karema C; Djimde A; Brasseur P; Sirima SB; Olliaro P
    Malar J; 2014 Mar; 13():114. PubMed ID: 24666562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.
    Adjei GO; Goka BQ; Enweronu-Laryea CC; Rodrigues OP; Renner L; Sulley AM; Alifrangis M; Khalil I; Kurtzhals JA
    Malar J; 2014 Sep; 13():369. PubMed ID: 25236838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
    Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015-2017.
    Abuaku B; Duah-Quashie NO; Quaye L; Matrevi SA; Quashie N; Gyasi A; Owusu-Antwi F; Malm K; Koram K
    Malar J; 2019 Jun; 18(1):206. PubMed ID: 31234874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.